CVE-2023-23918
A privilege escalation vulnerability exists in Node.js <19.6.1, <18.14.1, <16.19.1 and <14.21.3 that made it possible to bypass the experimental Permissions (https://nodejs.org/api/permissions.html) feature in Node.js and access non authorized modules…
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (2.02%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
A privilege escalation vulnerability exists in Node.js <19.6.1, <18.14.1, <16.19.1 and <14.21.3 that made it possible to bypass the experimental Permissions (https://nodejs.org/api/permissions.html) feature in Node.js and access non authorized modules by using process.mainModule.require(). This only affects users who had enabled the experimental permissions option with --experimental-policy.
- CVSS 3.1
- 7.5 HIGHCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
- EPSS
- 2.02% probability · 80th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-863
- Affected
- nodejs/node.js
- Source
- support@hackerone.com
References
- https://nodejs.org/en/blog/vulnerability/february-2023-security-releases/Patch, Vendor Advisory
- https://security.netapp.com/advisory/ntap-20230316-0008/
- https://nodejs.org/en/blog/vulnerability/february-2023-security-releases/Patch, Vendor Advisory
- https://security.netapp.com/advisory/ntap-20230316-0008/
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.